Drugdiscovery >> Pharmaceutical Companies >> News
5009
Views
Sanofi - Pozen deal - drugdiscovery.com
Sanofi - Pozen deal - drugdiscovery.com


The two companies agreed that Sanofi handles U.S. marketing of Pozen’s experimental cardiovascular drugs PA8140 and PA32540, intended as an alternative to aspirin as a secondary treatment for the prevention of cardiovascular disease.
Read More >>


Tags: Sanofi, Pozen, deal, agreement, US marketing, experimental cardiovascular drugs, PA8140, PA32540 - September 7, 2013
Related Articles
3220
Views
UCB and Sanofi started a new partnership UCB and Sanofi started a new partnership
Belgium-based UCB and Sanofi announced that they entered into a new strategic partnership.The new contract aims to develop treatmens for immune-based diseases in the field of gastroenterology and arth Read More >>

Tags: Sanofi, UCB , arthritis, gastroenterology

3655
Views
Sanofi's profilts fall Sanofi's profilts fall
Sanofi hurt by generic competition and Brazil woes Read More >>

Tags: Sanofi, profit

4594
Views
AbbVie’s cystic fibrosis deal AbbVie’s cystic fibrosis deal
AbbVie enters into collaboration with Dutch drug developer Galapagos NV with the aim to study treatments for cystic fibrosis. The deal could be worth more than $405 million to Galapagos. Read More >>

Tags: AbbVie, Galapagos, cystic fibrosis, deal

6246
Views
Merck, AstraZeneca ovarian cancer drug deal Merck, AstraZeneca ovarian cancer drug deal
AstraZeneca will take over from Merck the clinical development of a potential ovarian cancer treatment , MK-1775, which is in mid-stage clinical testing as a possible oral treatment for certain form Read More >>

Tags: Merck, AstraZeneca, deal, ovarian cancer, drug, development

1510
Views
Start-ups in the fielf of Drug Discovery are blossoming Start-ups in the fielf of Drug Discovery are blossoming
Lilly, Celgene, Sanofi, Roche are pioneers of a new way of grounding companies. Start-ups are now blossoming. The quesiton is how sustainable this technology will prove to be. Read More >>

Tags: start-up company, Lilly, Celgene, Sanofi, Roche

4291
Views
Bayer and Compugen signed a deal Bayer and Compugen signed a deal
The collaboration centres around the development of antibody-based therapeutics for cancer immunotherapy. Read More >>

Tags: collaboration, Bayer, Compugen, cancer immunotherapy

1591
Views
Actavis buys Warner Chilcott Actavis buys Warner Chilcott
Shareholders of Actavis and Ireland-based Warner Chilcott have approved the deal which will make the new Actavis the third-largest specialty pharmaceutical company in the U.S. market. The deal is ex Read More >>

Tags: Actavis, Warner Chilcott, deal, purchase

2117
Views
Otsuka to buy Astex Otsuka to buy Astex
Otsuka Pharmaceutical Co. will buy Astex Pharmaceuticals Inc. for about $804.1 million in cash. Otsuka expects this purchase to boost its research capabilities and pipeline of products for neuroscienc Read More >>

Tags: Otsuka, Astex, purchase, deal, Otsuka Pharmaceutical, Astex Pharmaceuticals

2907
Views
Amgen will buy Onyx Pharmaceuticals Amgen will buy Onyx Pharmaceuticals
The biotech giant Amgen will buy cancer drug maker Onyx Pharmaceuticals for $10.4 billion. The purchase is expected to close early in the fourth quarter. Amgen gets this way three approved cancer tre Read More >>

Tags: Amgen, Onyx Pharmaceuticals, purchase, buy, deal

1567
Views
Pharmaceutical companies team up to deal with Pharmaceutical companies team up to deal with "big data challenge"
Cancer Research UK says it teams up with other oharmaceutical and technical companies to solve the big data problems. huge amounts of DATA received from studies is going to be analyzed now. Read More >>

Tags: DATA, analisys, study, big data, cancer research, big data cancer research, Cancer research UK

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013